共 12 条
[2]
Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?*[J] . Elliot V. Hersh,Edward T. Lally,Paul A. Moore.Current Medical Research and Opinion? . 2005 (8)
[3]
Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?[J] . J. A. Paramo,J. A. Rodriguez,O. Beloqui,J. Orbe.Current Drug Target -Cardiovascular & Hematologic . 2005 (4)
[7]
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association[J] . Thomas A. Pearson,George A. Mensah,R. Wayne Alexander,Jeffrey L. Anderson,Richard O. Cannon,Michael Criqui,Yazid Y. Fadl,Stephen P. Fortmann,Yuling Hong,Gary L. Myers,Nader Rifai,Sidney C. Smith,Kathryn Taubert,Russell P. Tracy,Frank Vinicor.Circulation: Journal
[9]
Comparison of thromboembolic events in patients treated with Celecoxib , a Cyclooxygenase-2 specific inhibitor, versus Ibuprofen or Diclofenac[J] . William B White,Gerald Faich,Andrew Whelton,Clement Maurath,Nancy J Ridge,Kenneth M Verburg,G.Steven Geis,James B Lefkowith.The American Journal of Cardiology . 2002 (4)